Bio-Rad Laboratories, Inc. (NYSE:BIO.B – Get Free Report) shares gapped down before the market opened on Thursday . The stock had previously closed at $357.65, but opened at $343.85. Bio-Rad Laboratories shares last traded at $343.85, with a volume of 231 shares traded.
Bio-Rad Laboratories Price Performance
The company has a debt-to-equity ratio of 0.16, a current ratio of 6.14 and a quick ratio of 4.52. The stock’s fifty day simple moving average is $338.49 and its 200-day simple moving average is $331.77. The stock has a market cap of $9.63 billion, a P/E ratio of -12.58 and a beta of 0.73.
Bio-Rad Laboratories Company Profile
Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.
Featured Articles
- Five stocks we like better than Bio-Rad Laboratories
- The How and Why of Investing in Gold Stocks
- Chipotle’s Slip: A Short-Term Dip or Long-Term Opportunity?
- What is MarketRank™? How to Use it
- Why New Tariffs Could Boost These 3 Basic Materials Stocks
- Basic Materials Stocks Investing
- MarketBeat Week in Review – 02/03 – 02/07
Receive News & Ratings for Bio-Rad Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bio-Rad Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
